SPONSOR
Chulalongkorn University
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 2, Phase 3
Chulalongkorn University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Hyperpigmentation, Contraception, Empagliflozin in Cardiorenal Syndrome Type 1.
The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Chulalongkorn University
How many clinical trials has Chulalongkorn University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Chulalongkorn University, of which 3 are actively recruiting participants. These trials cover conditions including Hyperpigmentation, Contraception, Empagliflozin in Cardiorenal Syndrome Type 1. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chulalongkorn University research focus on?
Chulalongkorn University clinical trials span Hyperpigmentation, Contraception, Empagliflozin in Cardiorenal Syndrome Type 1. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Chulalongkorn University clinical trial?
To participate in a Chulalongkorn University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chulalongkorn University trials with current recruitment status updated daily.
Clinical Trials by Chulalongkorn University
NCT07067879
Recruiting
The Effectiveness of a Novel Lip Product Containing Caulerpa Lentillifera Extract for Reducing Lip Hyperpigmentation
Hyperpigmentation
NCT06345560 Phase 1, Phase 2
Recruiting
Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study
Contraception
NCT06030843 Phase 2, Phase 3
Recruiting
The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1
Empagliflozin in Cardiorenal Syndrome Type 1
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology